Fri, August 9, 2024

Roy Buchanan Maintained (ANTX) at Buy with Decreased Target to $3 on, Aug 9th, 2024


//stocks-investing.news-articles.net/content/202 .. -with-decreased-target-to-3-on-aug-9th-2024.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Roy Buchanan of JMP Securities, Maintained "AN2 Therapeutics, Inc." (ANTX) at Buy with Decreased Target from $6 to $3 on, Aug 9th, 2024.

Roy has made no other calls on ANTX in the last 4 months.



There are 2 other peers that have a rating on ANTX. Out of the 2 peers that are also analyzing ANTX, 1 agrees with Roy's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Liisa Bayko of "Evercore ISI Group" Maintained at Hold with Decreased Target to $2 on, Thursday, May 16th, 2024


This is the rating of the analyst that currently disagrees with Roy


  • Joseph Schwartz of "Leerink Partners" Upgraded from Hold to Buy on, Wednesday, July 3rd, 2024

Publication Contributing Sources